Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A B cell-driven EAE mouse model reveals the impact of B cell-derived cytokines on CNS autoimmunity. | Proc Natl Acad Sci U S A | 2023 | 37956299 | PubTator, text mining | PubMed |
| IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies. | Front Immunol | 2023 | 37954584 | PubTator, text mining | PubMed |
| [Molecular diagnostics for vitreoretinal lymphoma]. | Pathologie (Heidelb) | 2023 | 37947807 | PubTator, text mining | PubMed |
| Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial. | RMD Open | 2023 | 37945284 | PubTator, text mining | PubMed |
| Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. | Hemasphere | 2023 | 37928625 | PubTator, text mining | PubMed |
| High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis. | J Cancer | 2023 | 37928429 | PubTator, text mining | PubMed |
| Annotation of cell types (ACT): a convenient web server for cell type annotation. | Genome Med | 2023 | 37924118 | PubTator, text mining | PubMed |
| Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma. | Cancer Sci | 2023 | 37921363 | PubTator, text mining | PubMed |
| A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders. | JCI Insight | 2023 | 37917882 | PubTator, text mining | PubMed |
| Radiotherapy for Non-Hodgkin's lymphoma with cardiac infiltration: A case report. | Front Oncol | 2023 | 37916159 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma. | Sci Rep | 2023 | 37914817 | PubTator, text mining | PubMed |
| Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis. | Front Immunol | 2023 | 37908350 | PubTator, text mining | PubMed |
| Clinical Features and Outcomes of Primary Breast Diffuse Large B-Cell Lymphoma: A Matched-Pair Study. | Clin Med Insights Oncol | 2023 | 37905234 | PubTator, text mining | PubMed |
| Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis. | Nat Commun | 2023 | 37903821 | PubTator, text mining | PubMed |
| Differences in CpG island distribution between exogenous and endogenous jaagsiekte sheep retrovirus strains. | Vet Res Forum | 2023 | 37901353 | PubTator, text mining | PubMed |
Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy. | Front Immunol | 2023 | 37901220 | PubTator, text mining | PubMed |
| Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine. | J Immunother Cancer | 2023 | 37899130 | PubTator, text mining | PubMed |
| Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. | Int J Mol Sci | 2023 | 37894816 | PubTator, text mining | PubMed |
| Clinical advances in immunotherapy for immune-mediated glomerular diseases. | Clin Exp Med | 2023 | 37889398 | PubTator, text mining | PubMed |
| Peptides from Marine-Derived Fungi: Chemistry and Biological Activities. | Mar Drugs | 2023 | 37888445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=21